Clinical Research Directory
Browse clinical research sites, groups, and studies.
Role of Oral Voriconazole in the Treatment of Resistant Dermatophyte Infections
Sponsor: Sheikh Zayed Medical College
Summary
Treatment of dermatophyte infection in our country (Pakistan) is becoming difficult due to the developing resistance to traditional antifungal agents. Assessing the effectiveness ,feasibility and standard dosage of a newer antifungal drug like voriconazole is the need of the hour in resistant cases of dermatophyte infection.
Official title: Comparing the Efficacy of Oral 200 Milligram Voriconazole Once a Day Vs. Twice a Day in the Treatment of Resisitant Dermatophyte Infections (Tinea Corporis and Tinea Cruris)
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2024-11-15
Completion Date
2025-03-15
Last Updated
2024-11-08
Healthy Volunteers
No
Conditions
Interventions
Voriconazole high dose
Oral voriconazole 200mg once a day for a maximum of 28 days
Voriconazole low dose
Oral voriconazole 200mg twice a day for a maximum of 28 days
Locations (1)
Sheikh zayed Medical College and Hospital
Rahim Yar Khan, Punjab Province, Pakistan